Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading causes of neoplastic morbidity and mortality worldwide, and despite recent treatment advances, the prognosis remains dismal, with a 5-year mortality rate of 85%. The surveillance and timely diagnosis is therefore of crucial importance in order to...

Full description

Bibliographic Details
Main Authors: Pedro Boal Carvalho, Eduardo Pereira
Format: Article
Language:English
Published: Karger Publishers 2015-07-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2341454515000538
id doaj-9e2db903935b45d2a650eb2493e42f94
record_format Article
spelling doaj-9e2db903935b45d2a650eb2493e42f942020-11-25T03:20:10ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452015-07-0122415316010.1016/j.jpge.2015.04.002Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular CarcinomaPedro Boal Carvalho0Eduardo Pereira1Gastroenterology Department, Centro Hospitalar do Alto Ave, Guimarães, PortugalGastroenterology Department, Hospital Amato Lusitano, Unidade Local de Saúde de Castelo Branco, Castelo Branco, PortugalHepatocellular carcinoma (HCC) is one of the leading causes of neoplastic morbidity and mortality worldwide, and despite recent treatment advances, the prognosis remains dismal, with a 5-year mortality rate of 85%. The surveillance and timely diagnosis is therefore of crucial importance in order to improve survival rates and alleviate the health burden imposed by the HCC. Previously, HCC diagnosis warranted liver biopsy, an invasive process with limited diagnostic accuracy. In the past 15 years, HCC diagnosis based solely on imaging criteria was accepted by all the major national and international guidelines, and is now widely employed across the globe. Current European guidelines for the HCC diagnosis support the use of both dynamic contrasted computer tomography as well as magnetic resonance imaging for the non-invasive diagnosis of HCC for nodules >1 cm in a cirrhotic liver. The non-invasive diagnosis of HCC depends on radiological hallmarks, such as homogeneous contrast uptake during the arterial phase and wash-out during the venous and late phases, but while such tumoral behaviour is frequent in nodules >2 cm, high-end equipment and superior expertise is often needed for the correct diagnosis of early HCC. Nevertheless, the accuracy of imaging techniques for the diagnosis of HCC is permanently improving, and supports the progressively reduced need for liver biopsy during liver nodule workout in a cirrhotic liver.http://www.sciencedirect.com/science/article/pii/S2341454515000538Carcinoma, Hepatocellular/diagnosisCarcinogenesisDiagnostic ImagingMagnetic Resonance ImagingUltrasonography
collection DOAJ
language English
format Article
sources DOAJ
author Pedro Boal Carvalho
Eduardo Pereira
spellingShingle Pedro Boal Carvalho
Eduardo Pereira
Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
GE: Portuguese Journal of Gastroenterology
Carcinoma, Hepatocellular/diagnosis
Carcinogenesis
Diagnostic Imaging
Magnetic Resonance Imaging
Ultrasonography
author_facet Pedro Boal Carvalho
Eduardo Pereira
author_sort Pedro Boal Carvalho
title Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
title_short Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
title_full Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
title_fullStr Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
title_full_unstemmed Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma
title_sort imagiological diagnosis of gastrointestinal diseases – diagnostic criteria of hepatocellular carcinoma
publisher Karger Publishers
series GE: Portuguese Journal of Gastroenterology
issn 2341-4545
publishDate 2015-07-01
description Hepatocellular carcinoma (HCC) is one of the leading causes of neoplastic morbidity and mortality worldwide, and despite recent treatment advances, the prognosis remains dismal, with a 5-year mortality rate of 85%. The surveillance and timely diagnosis is therefore of crucial importance in order to improve survival rates and alleviate the health burden imposed by the HCC. Previously, HCC diagnosis warranted liver biopsy, an invasive process with limited diagnostic accuracy. In the past 15 years, HCC diagnosis based solely on imaging criteria was accepted by all the major national and international guidelines, and is now widely employed across the globe. Current European guidelines for the HCC diagnosis support the use of both dynamic contrasted computer tomography as well as magnetic resonance imaging for the non-invasive diagnosis of HCC for nodules >1 cm in a cirrhotic liver. The non-invasive diagnosis of HCC depends on radiological hallmarks, such as homogeneous contrast uptake during the arterial phase and wash-out during the venous and late phases, but while such tumoral behaviour is frequent in nodules >2 cm, high-end equipment and superior expertise is often needed for the correct diagnosis of early HCC. Nevertheless, the accuracy of imaging techniques for the diagnosis of HCC is permanently improving, and supports the progressively reduced need for liver biopsy during liver nodule workout in a cirrhotic liver.
topic Carcinoma, Hepatocellular/diagnosis
Carcinogenesis
Diagnostic Imaging
Magnetic Resonance Imaging
Ultrasonography
url http://www.sciencedirect.com/science/article/pii/S2341454515000538
work_keys_str_mv AT pedroboalcarvalho imagiologicaldiagnosisofgastrointestinaldiseasesdiagnosticcriteriaofhepatocellularcarcinoma
AT eduardopereira imagiologicaldiagnosisofgastrointestinaldiseasesdiagnosticcriteriaofhepatocellularcarcinoma
_version_ 1724619119647522816